Showing results (321-330 of 510) with videos related to
Sort By:
Pageof 51
Clinical and Experimental Immunology|December 9, 1998
Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapyT F Logan, B Banner, U Rao, et al.The American Journal of Pathology|May 1, 1995
Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancersM F Melhem, J C Law, L el-Ashmawy, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancerT G Ehlen, P J Hoskins, D Miller, et al.Hepatology (Baltimore, Md.)|February 1, 1997
The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functionsA Francavilla, N L Vujanovic, L Polimeno, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4J N Myers, S Yasumura, Y Suminami, et al.Molecular and Cellular Biochemistry|November 2, 1999
Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cellsR L Meighan-Mantha, A T Riegel, S Suy, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variantsT K Hoffmann, K Nakano, E M Elder, et al.The British Journal of Dermatology|February 21, 2008
Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulationM Meissner, T L Whiteside, P van Kuik-Romein, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
Changes of liver-resident NK cells during liver regeneration in ratsN L Vujanovic, L Polimeno, A Azzarone, et al.Cell Death and Differentiation|January 31, 2009
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell deathM Czystowska, J Han, M J Szczepanski, et al.Pageof 51